A Phase II trial of pembrolizumab for patients with melanoma or non-small cell lung cancer and untreated brain metastases

Por Goldberg, Sarah B., Gettinger, Scott N., Mahajan, Amit, Chiang, Anne C., Herbst, Roy S., Sznol, Mario, Tsiouris, Apostolos John, Cohen, Justine, Vortmeyer, Alexander, Jilaveanu, Lucia, Yu, James, Hegde, Upendra, Speaker, Stephanie, Madura, Matthew, Ralabate, Amanda, Rivera, Angel, Rowen, Elin, Gerrish, Heather, Yao, Xiaopan, Chiang, Veronica, Kluger, Harriet M.
Publicado no Lancet Oncol (2016)

Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2

Por Chimge, Nyam-Osor, Baniwal, Sanjeev K, Little, Gillian H, Chen, Yi-bu, Kahn, Michael, Tripathy, Debu, Borok, Zea, Frenkel, Baruch
Publicado em 2011

Correlation of MicroRNA 132 Up-regulation with an Unfavorable Clinical Outcome in Patients with Primary Glioblastoma Multiforme Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide...

Por Parker, Nicole R, Correia, Nelson, Crossley, Brendan, Buckland, Michael E, Howell, Viive M, Wheeler, Helen R
Publicado em 2013

Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal microRNA to promote brain metastasis

Por Xing, Fei, Liu, Yin, Wu, Shin-Ying, Wu, Kerui, Sharma, Sambad, Mo, Yin-Yuan, Feng, Jiamei, Sanders, Stephanie, Jin, Guangxu, Singh, Ravi, Vidi, Pierre-Alexandre, Tyagi, Abhishek, Chan, Michael D., Ruiz, Jimmy, Debinski, Waldemar, Pasche, Boris C., Lo, Hui-Wen, Metheny-Barlow, Linda J., D’Agostino, Ralph B., Watabe, Kounosuke
Publicado no Cancer Res (2018)

MEDU-11. MOLECULAR CHARACTERIZATION OF ETMRs REVEALS A ROLE FOR R-LOOP MEDIATED CHROMOSOMAL INSTABILITY

Por Lambo, Sander, Gröbner, Susanne, Rausch, Tobias, Waszak, Sebastian, Schmidt, Christin, Gorthi, Aparna, Romero, Carolina, Mauermann, Monika, Brabetz, Sebastian, Krausert, Sonja, Uro-Coste, Emmanuelle, Bourdeaut, Franck, Huang, Annie, Bishop, Alexander, Pfister, Stefan, Korshunov, Andrey, Kool, Marcel
Publicado no Neuro Oncol (2019)

Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients

Por Kustrimovic, Natasa, Comi, Cristoforo, Magistrelli, Luca, Rasini, Emanuela, Legnaro, Massimiliano, Bombelli, Raffaella, Aleksic, Iva, Blandini, Fabio, Minafra, Brigida, Riboldazzi, Giulio, Sturchio, Andrea, Mauri, Marco, Bono, Giorgio, Marino, Franca, Cosentino, Marco
Publicado no J Neuroinflammation (2018)

MiR-325-3p functions as a suppressor miRNA and inhibits the proliferation and metastasis of glioma through targeting FOXM1

Por Qijiang Xiong, Hai Su
Publicado em 2021-12-01

PARP-1–Targeted Radiotherapy in Mouse Models of Glioblastoma

Por Jannetti, Stephen A., Carlucci, Giuseppe, Carney, Brandon, Kossatz, Susanne, Shenker, Larissa, Carter, Lukas M., Salinas, Beatriz, Brand, Christian, Sadique, Ahmad, Donabedian, Patrick L., Cunanan, Kristen M., Gönen, Mithat, Ponomarev, Vladimir, Zeglis, Brian M., Souweidane, Mark M., Lewis, Jason S., Weber, Wolfgang A., Humm, John L., Reiner, Thomas
Publicado no J Nucl Med (2018)

Oxygen transport to tissue xxxv

Por International Society on Oxygen Transport to Tissue (ISOTT), Van Huffel, Sabine.
Publicado em 2013

Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma specimens

Por Pedron, Sara, Wolter, Gabrielle L., Chen, Jee-Wei E., Laken, Sarah E., Sarkaria, Jann N., Harley, Brendan A. C.
Publicado no Biomaterials (2019)

SOX2 IDENTIFIES THE TREATMENT-REFRACTORY STEM CELL POPULATION IN GROUP 2 MEDULLOBLASTOMA

Por Singh, Sheila K., Manoranjan, Branavan, Venugopal, Chitra, Vora, Parvez, McFarlane, Nicole, Garg, Neha, Singh, Mohini, Mann, Aneetinder, Bakhshinyan, David, Mahendran, Sujeivan, Dunn, Sandra
Publicado em 2014

RTHP-09. DYSREGULATION OF Wnt SIGNALING PATHWAY CORRELATES WITH TREATMENT OUTCOME IN GLIOBLASTOMA MULTIFORME

Por Weterings, Eric, Morrison, Christopher, Gravbrot, Nicholas, Hammer, Michael, Mahadevan, Daruka, Stea, Baldassarre
Publicado no Neuro Oncol (2018)

The XPO1 inhibitor Selinexor inhibits translation and enhances the radiosensitivity of glioblastoma cells grown in vitro and in vivo

Por Wahba, Amy, Rath, Barbara H., O’Neill, John W., Camphausen, Kevin, Tofilon, Philip J.
Publicado no Mol Cancer Ther (2018)

DRES-16. HYPOXIC MICROENVIRONMENT DETECTED BY FRP-170 PET MAY INDUCE THE EXPRESSION OF DRUG RESISTANCE GENES IN THE PATIENT WITH GLIOBLASTOMA

Por Abe, Tatsuya, Morisaki, Ikuko, Momii, Yasutomo, Fudaba, Takahiro, Fujiki, Minoru, Kouguchi, Motofumi, Ito, Hiroshi, Wakamiya, Tomihiro, Nakahara, Yukiko
Publicado no Neuro Oncol (2018)

P08.34 Targeting glioma stem cells with interferon-β

Por Lohmann, B., Szabo, E.
Publicado no Neuro Oncol (2017)

EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation

Por Neumann, Lisa C, Weinhäusel, Andreas, Thomas, Stefanie, Horsthemke, Bernhard, Lohmann, Dietmar R, Zeschnigk, Michael
Publicado em 2011

Organ microcirculation a gateway to diagnostic and therapeutic interventions /

Por Ishii, Hiromasa., Keio International Symposium for Life Sciences and Medicine
Publicado em 2005

P01.11 ATF4 AS A MEDIATOR OF RESISTANCE TO TARGETED THERAPY IN HIGH-GRADE GLIOMAS

Por Moeckel, S., Neyns, B., Pan, E., Riemenschneider, M., Bosserhoff, A., Vollmann-Zwerenz, A., Hau, P.
Publicado em 2014

Brivaracetam in the treatment of epilepsy: a review of clinical trial data

Por Feyissa, Anteneh M
Publicado no Neuropsychiatr Dis Treat (2019)

Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis

Por Nijaguna, Mamatha Bangalore, Patil, Vikas, Urbach, Serge, Shwetha, Shivayogi D., Sravani, Kotha, Hegde, Alangar S., Chandramouli, Bangalore A., Arivazhagan, Arimappamagan, Marin, Philippe, Santosh, Vani, Somasundaram, Kumaravel
Publicado no J Biol Chem (2015)